Aifred uses AI to accomplish what was previously not possible with other methods: helping clinicians and patients make better choices when presented with a large number of treatments that are all similarly effective at the population level, but not at the individual patient level. Along with a network of domain experts in psychiatry, we are harnessing the power of AI to better understand patterns in patient data that can predict optimal treatment. Aifred plans to encompass a broad spectrum of mental health conditions, leveraging their treatment-agnostic AI model. At its core, Aifred is focused on bringing better mental healthcare to all. We are a proud official IBM Watson AI XPRIZE finalist team, headquartered in Montreal, Canada.